Exhibit 99.1
MetLife, Inc.
Unaudited Pro Forma Condensed Consolidated Financial Statements
On August 4, 2017, MetLife, Inc. distributed 96,776,670 shares of Brighthouse Financial, Inc.’s (“Brighthouse”) common stock, representing approximately 80.8% of those shares, on a pro rata basis to MetLife, Inc.’s common shareholders (the “Distribution”). The record date for the Distribution was 5:00 p.m., New York City time, on July 19, 2017. MetLife, Inc. common shareholders received one share of Brighthouse common stock for every 11 shares of MetLife, Inc. common stock they owned. MetLife, Inc.’s common shareholders who owned less than 11 shares of common stock, or who would otherwise have received fractional shares, will receive cash. MetLife, Inc. retained 22,996,436 shares of Brighthouse common stock. Brighthouse common stock began trading on The NASDAQ Stock Market LLC under the symbol “BHF” on August 7, 2017.
The following unaudited pro forma condensed consolidated financial statements and accompanying notes present the impact of the Distribution and transactions directly attributable to the Distribution on the historical condensed consolidated financial statements of MetLife, Inc. and its subsidiaries (collectively, “MetLife, Inc.” or the “Company”). Beginning in the third quarter of 2017, Brighthouse’s historical financial results will be reported in MetLife, Inc.’s consolidated financial statements as discontinued operations.
The unaudited pro forma condensed consolidated financial statements include historical unaudited amounts as of June 30, 2017 and for the six months ended June 30, 2017 and audited amounts for the years ended December 31, 2016, 2015 and 2014 for MetLife, Inc. Within the unaudited pro forma condensed consolidated financial statements, the Brighthouse Financial Separation column includes historical amounts reported by MetLife, Inc.’s Brighthouse Financial segment adjusted to exclude the impact of historical intercompany transactions between Brighthouse and MetLife, Inc. subsidiaries that had previously been eliminated in consolidation and to exclude previously allocated corporate overhead costs. Refer to the accompanying footnotes for further information.
The unaudited pro forma condensed consolidated financial statements give effect to the Distribution as if it had occurred on (i) June 30, 2017 for purposes of the unaudited pro forma condensed consolidated balance sheet and (ii) January 1, 2014 for purposes of the unaudited pro forma condensed consolidated statements of operations for the six months ended June 30, 2017 and for the years ended December 31, 2016, 2015 and 2014. The historical financial information has been adjusted in the unaudited pro forma condensed consolidated financial statements to give effect to pro forma events that are directly attributable to the Distribution and that are factually supportable and are expected to have a continuing impact on MetLife, Inc.’s results of operations. Actual results may differ from pro forma adjustments.
The unaudited pro forma condensed consolidated financial statements, filed as Exhibit 99.1 to the Current Report on Form8-K, should be read in conjunction with the accompanying notes. In addition, the unaudited pro forma condensed consolidated financial statements were derived in part from, and should be read in conjunction with, the historical unaudited interim condensed consolidated financial statements of MetLife, Inc. included in MetLife, Inc.’s quarterly report on Form10-Q for the six months ended June 30, 2017 and the historical audited consolidated financial statements of MetLife, Inc. included in MetLife, Inc.’s annual report on Form10-K for the year ended December 31, 2016.
The unaudited pro forma condensed consolidated financial statements (i) are presented based on information currently available, (ii) are intended for informational purposes only, and (iii) are not intended to reflect the results of operations or the financial position of the Company that would have resulted had the Distribution been effective as of and during the periods presented or the results that may be obtained by the Company in the future. The unaudited pro forma condensed consolidated financial statements as of and for the periods presented do not reflect future events that are not directly attributable to the Distribution and that may occur after the Distribution. Future results may vary significantly from the results reflected in the unaudited pro forma condensed consolidated financial statements.
1
MetLife, Inc.
Unaudited Pro Forma Condensed Consolidated Balance Sheet
June 30, 2017
(In millions, except per share data)
| | | | | | | | | | | | | | | | | | | | |
| | Historical MetLife, Inc. | | | Brighthouse Financial Separation (a) | | | Pro Forma Adjustments | | | Notes | | | Pro Forma MetLife, Inc. | |
Assets | | | | | | | | | | | | | | | | | | | | |
Investments: | | | | | | | | | | | | | | | | | | | | |
Fixed maturity securitiesavailable-for-sale, at estimated fair value | | $ | 364,084 | | | $ | (63,507 | ) | | $ | — | | | | | | | $ | 300,577 | |
Equity securitiesavailable-for-sale, at estimated fair value | | | 3,415 | | | | (278 | ) | | | — | | | | | | | | 3,137 | |
Fair value option securities, at estimated fair value | | | 14,762 | | | | — | | | | 1,443 | | | | (b) | | | | 16,205 | |
Mortgage loans | | | 77,572 | | | | (10,263 | ) | | | 61 | | | | (c) | | | | 67,370 | |
Policy loans | | | 11,072 | | | | (1,513 | ) | | | — | | | | | | | | 9,559 | |
Real estate and real estate joint ventures | | | 9,484 | | | | (302 | ) | | | — | | | | | | | | 9,182 | |
Other limited partnership interests | | | 6,874 | | | | (1,623 | ) | | | — | | | | | | | | 5,251 | |
Short-term investments, principally at estimated fair value | | | 7,177 | | | | (1,286 | ) | | | — | | | | | | | | 5,891 | |
Other invested assets, principally at estimated fair value | | | 19,596 | | | | (3,037 | ) | | | 1,438 | | | | (d) | | | | 17,997 | |
| | | | | | | | | | | | | | | | | | | | |
Total investments | | | 514,036 | | | | (81,809 | ) | | | 2,942 | | | | | | | | 435,169 | |
Cash and cash equivalents, principally at estimated fair value | | | 17,319 | | | | (4,443 | ) | | | 1,798 | | | | (e) | | | | 14,674 | |
Accrued investment income | | | 3,970 | | | | (608 | ) | | | — | | | | | | | | 3,362 | |
Premiums, reinsurance and other receivables | | | 26,487 | | | | (10,008 | ) | | | 2,602 | | | | (c), (d) | | | | 19,081 | |
Deferred policy acquisition costs and value of business acquired | | | 25,408 | | | | (7,369 | ) | | | 4 | | | | (c), (d) | | | | 18,043 | |
Current income tax recoverable | | | 66 | | | | (1,463 | ) | | | — | | | | | | | | (1,397 | ) |
Goodwill | | | 9,385 | | | | — | | | | — | | | | | | | | 9,385 | |
Other assets | | | 8,073 | | | | (599 | ) | | | — | | | | | | | | 7,474 | |
Separate account assets | | | 320,455 | | | | (115,566 | ) | | | — | | | | | | | | 204,889 | |
| | | | | | | | | | | | | | | | | | | | |
Total assets | | $ | 925,199 | | | $ | (221,865 | ) | | $ | 7,346 | | | | | | | $ | 710,680 | |
| | | | | | | | | | | | | | | | | | | | |
Liabilities and Equity | | | | | | | | | | | | | | | | | | | | |
Liabilities | | | | | | | | | | | | | | | | | | | | |
Future policy benefits | | $ | 205,836 | | | $ | (34,494 | ) | | $ | 1,747 | | | | (d) | | | $ | 173,089 | |
Policyholder account balances | | | 216,257 | | | | (37,296 | ) | | | — | | | | | | | | 178,961 | |
Other policy-related balances | | | 14,708 | | | | (1,294 | ) | | | 1,428 | | | | (d) | | | | 14,842 | |
Policyholder dividends payable | | | 722 | | | | (15 | ) | | | — | | | | | | | | 707 | |
Policyholder dividend obligation | | | 2,237 | | | | — | | | | — | | | | | | | | 2,237 | |
Payables for collateral under securities loaned and other transactions | | | 33,725 | | | | (7,121 | ) | | | — | | | | | | | | 26,604 | |
Short-term debt | | | 235 | | | | — | | | | — | | | | | | | | 235 | |
Long-term debt | | | 19,508 | | | | (3,016 | ) | | | — | | | | | | | | 16,492 | |
Collateral financing arrangements | | | 1,235 | | | | — | | | | — | | | | | | | | 1,235 | |
Junior subordinated debt securities | | | 3,169 | | | | — | | | | — | | | | | | | | 3,169 | |
Deferred income tax liability | | | 10,383 | | | | (2,767 | ) | | | (750 | ) | | | (c) | | | | 6,866 | |
Other liabilities | | | 27,060 | | | | (4,763 | ) | | | 2,945 | | | | (c), (d) | | | | 25,242 | |
Separate account liabilities | | | 320,455 | | | | (115,566 | ) | | | — | | | | | | | | 204,889 | |
| | | | | | | | | | | | | | | | | | | | |
Total liabilities | | | 855,530 | | | | (206,332 | ) | | | 5,370 | | | | | | | | 654,568 | |
| | | | | | | | | | | | | | | | | | | | |
Equity | | | | | | | | | | | | | | | | | | | | |
MetLife, Inc.’s stockholder’s equity: | | | | | | | | | | | | | | | | | | | | |
Preferred stock, par value $0.01 per share; $2,100 aggregate liquidation preference | | | — | | | | — | | | | — | | | | | | | | — | |
Common stock, par value $0.01 per share | | | 12 | | | | — | | | | — | | | | | | | | 12 | |
Additionalpaid-in capital | | | 31,021 | | | | — | | | | — | | | | | | | | 31,021 | |
Retained earnings | | | 35,270 | | | | (13,713 | ) | | | 1,976 | | | | (f) | | | | 23,533 | |
Treasury stock, at cost | | | (5,284 | ) | | | — | | | | — | | | | | | | | (5,284 | ) |
Accumulated other comprehensive income (loss) | | | 8,436 | | | | (1,770 | ) | | | — | | | | | | | | 6,666 | |
| | | | | | | | | | | | | | | | | | | | |
Total MetLife, Inc.’s stockholder’s equity | | | 69,455 | | | | (15,483 | ) | | | 1,976 | | | | | | | | 55,948 | |
Noncontrolling interests | | | 214 | | | | (50 | ) | | | — | | | | | | | | 164 | |
| | | | | | | | | | | | | | | | | | | | |
Total equity | | | 69,669 | | | | (15,533 | ) | | | 1,976 | | | | | | | | 56,112 | |
| | | | | | | | | | | | | | | | | | | | |
Total liabilities and equity | | $ | 925,199 | | | $ | (221,865 | ) | | $ | 7,346 | | | | | | | $ | 710,680 | |
| | | | | | | | | | | | | | | | | | | | |
Book Value per share (g) | | | | | | | | | | | | | | | | | | | | |
Book value per common share | | $ | 63.37 | | | | | | | | | | | | | | | $ | 50.66 | |
| | | | | | | | | | | | | | | | | | | | |
Book value per common share, excluding accumulated other comprehensive income (loss) other than foreign currency translation adjustment | | $ | 51.03 | | | | | | | | | | | | | | | $ | 40.03 | |
| | | | | | | | | | | | | | | | | | | | |
Common shares outstanding, end of period | | | 1,063.5 | | | | | | | | | | | | | | | | 1,063.5 | |
| | | | | | | | | | | | | | | | | | | | |
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
2
MetLife, Inc.
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Six Months Ended June 30, 2017
(In millions, except per share data)
| | | | | | | | | | | | | | | | | | |
| | Historical MetLife, Inc. | | | Brighthouse Financial Separation (a) | | | Pro Forma Adjustments | | | Notes | | Pro Forma MetLife, Inc. | |
Revenues | | | | | | | | | | | | | | | | | | |
Premiums | | $ | 19,250 | | | $ | (704 | ) | | $ | 204 | | | (d) | | $ | 18,750 | |
Universal life and investment-type product policy fees | | | 4,604 | | | | (1,881 | ) | | | 12 | | | (d) | | | 2,735 | |
Net investment income | | | 10,155 | | | | (1,581 | ) | | | 33 | | | (d) | | | 8,607 | |
Other revenues | | | 756 | | | | (123 | ) | | | 68 | | | (d) | | | 701 | |
Net investment gains (losses) | | | 112 | | | | 55 | | | | — | | | | | | 167 | |
Net derivative gains (losses) | | | (1,363 | ) | | | 891 | | | | — | | | | | | (472 | ) |
| | | | | | | | | | | | | | | | | | |
Total revenues | | | 33,514 | | | | (3,343 | ) | | | 317 | | | | | | 30,488 | |
| | | | | | | | | | | | | | | | | | |
Expenses | | | | | | | | | | | | | | | | | | |
Policyholder benefits and claims | | | 20,161 | | | | (1,884 | ) | | | 187 | | | (d) | | | 18,464 | |
Interest credited to policyholder account balances | | | 3,274 | | | | (531 | ) | | | (28 | ) | | (d) | | | 2,715 | |
Policyholder dividends | | | 637 | | | | (13 | ) | | | 10 | | | (d) | | | 634 | |
Other expenses | | | 7,623 | | | | (713 | ) | | | (456 | ) | | (d), (h),
(i) | | | 6,454 | |
| | | | | | | | | | | | | | | | | | |
Total expenses | | | 31,695 | | | | (3,141 | ) | | | (287 | ) | | | | | 28,267 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) before provision for income tax | | | 1,819 | | | | (202 | ) | | | 604 | | | | | | 2,221 | |
Provision for income tax expense (benefit) | | | 103 | | | | 13 | | | | 211 | | | (j) | | | 327 | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) | | | 1,716 | | | | (215 | ) | | | 393 | | | | | | 1,894 | |
Less: Net income (loss) attributable to noncontrolling interests | | | 6 | | | | — | | | | — | | | | | | 6 | |
| | | | | | | | | | | | | | | | | | |
Net income (loss) attributable to MetLife, Inc. | | | 1,710 | | | | (215 | ) | | | 393 | | | | | | 1,888 | |
Less: Preferred stock dividends | | | 52 | | | | — | | | | — | | | | | | 52 | |
| | | | | | | | | | | | | | | | | | |
Net Income (loss) available to MetLife, Inc.’s common shareholders | | $ | 1,658 | | | $ | (215 | ) | | $ | 393 | | | | | $ | 1,836 | |
| | | | | | | | | | | | | | | | | | |
Earnings per share | | | | | | | | | | | | | | | | | | |
Net Income (loss) available to MetLife, Inc.’s common shareholders per common share: | | | | | | | | | | | | | | | | | | |
Basic | | $ | 1.53 | | | | | | | | | | | | | $ | 1.70 | |
| | | | | | | | | | | | | | | | | | |
Diluted | | $ | 1.52 | | | | | | | | | | | | | $ | 1.68 | |
| | | | | | | | | | | | | | | | | | |
Weighted average shares of common stock outstanding per common share: | | | | | | | | | | | | | | | | | | |
Basic | | | 1,082.1 | | | | | | | | | | | | | | 1,082.1 | |
| | | | | | | | | | | | | | | | | | |
Diluted | | | 1,090.4 | | | | | | | | | | | | | | 1,090.4 | |
| | | | | | | | | | | | | | | | | | |
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
3
MetLife, Inc.
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Year Ended December 31, 2016
(In millions, except per share data)
| | | | | | | | | | | | | | | | | | |
| | Historical MetLife, Inc. | | | Brighthouse Financial Separation (a) | | | Pro Forma Adjustments | | | Notes | | Pro Forma MetLife, Inc. | |
Revenues | | | | | | | | | | | | | | | | | | |
Premiums | | $ | 39,153 | | | $ | (1,954 | ) | | $ | 491 | | | (d) | | $ | 37,690 | |
Universal life and investment-type product policy fees | | | 9,206 | | | | (3,724 | ) | | | 17 | | | (d) | | | 5,499 | |
Net investment income | | | 19,947 | | | | (3,257 | ) | | | 65 | | | (d) | | | 16,755 | |
Other revenues | | | 1,759 | | | | (75 | ) | | | (4 | ) | | (d) | | | 1,680 | |
Net investment gains (losses) | | | 171 | | | | 77 | | | | — | | | | | | 248 | |
Net derivative gains (losses) | | | (6,760 | ) | | | 5,886 | | | | (35 | ) | | (d) | | | (909 | ) |
| | | | | | | | | | | | | | | | | | |
Total revenues | | | 63,476 | | | | (3,047 | ) | | | 534 | | | | | | 60,963 | |
| | | | | | | | | | | | | | | | | | |
Expenses | | | | | | | | | | | | | | | | | | |
Policyholder benefits and claims | | | 40,804 | | | | (4,487 | ) | | | 429 | | | (d) | | | 36,746 | |
Interest credited to policyholder account balances | | | 6,282 | | | | (1,107 | ) | | | (58 | ) | | (d) | | | 5,117 | |
Policyholder dividends | | | 1,256 | | | | (34 | ) | | | 27 | | | (d) | | | 1,249 | |
Goodwill impairment | | | 260 | | | | (260 | ) | | | — | | | | | | — | |
Other expenses | | | 15,069 | | | | (851 | ) | | | 230 | | | (d), (h), (i) | | | 14,448 | |
| | | | | | | | | | | | | | | | | | |
Total expenses | | | 63,671 | | | | (6,739 | ) | | | 628 | | | | | | 57,560 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations before provision for income tax | | | (195 | ) | | | 3,692 | | | | (94 | ) | | | | | 3,403 | |
Provision for income tax expense (benefit) | | | (999 | ) | | | 1,440 | | | | (33 | ) | | (j) | | | 408 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | 804 | | | | 2,252 | | | | (61 | ) | | | | | 2,995 | |
Less: Income (loss) from continuing operations attributable to noncontrolling interests | | | 4 | | | | — | | | | — | | | | | | 4 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations attributable to MetLife, Inc. | | | 800 | | | | 2,252 | | | | (61 | ) | | | | | 2,991 | |
Less: Preferred stock dividends | | | 103 | | | | — | | | | — | | | | | | 103 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders | | $ | 697 | | | $ | 2,252 | | | $ | (61 | ) | | | | $ | 2,888 | |
| | | | | | | | | | | | | | | | | | |
Earnings per share | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income taxes, available to MetLife, Inc.’s common shareholders per common share: | | | | | | | | | | | | | | | | | | |
Basic | | $ | 0.63 | | | | | | | | | | | | | $ | 2.62 | |
| | | | | | | | | | | | | | | | | | |
Diluted | | $ | 0.63 | | | | | | | | | | | | | $ | 2.60 | |
| | | | | | | | | | | | | | | | | | |
Weighted average shares of common stock outstanding per common share: | | | | | | | | | | | | | | | | | | |
Basic | | | 1,100.5 | | | | | | | | | | | | | | 1,100.5 | |
| | | | | | | | | | | | | | | | | | |
Diluted | | | 1,108.5 | | | | | | | | | | | | | | 1,108.5 | |
| | | | | | | | | | | | | | | | | | |
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
4
MetLife, Inc.
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Year Ended December 31, 2015
(In millions, except per share data)
| | | | | | | | | | | | | | | | | | |
| | Historical MetLife, Inc. | | | Brighthouse Financial Separation (a) | | | Pro Forma Adjustments | | | Notes | | Pro Forma MetLife, Inc. | |
Revenues | | | | | | | | | | | | | | | | | | |
Premiums | | $ | 38,545 | | | $ | (2,135 | ) | | $ | 243 | | | (d) | | $ | 36,653 | |
Universal life and investment-type product policy fees | | | 9,507 | | | | (3,936 | ) | | | (4 | ) | | (d) | | | 5,567 | |
Net investment income | | | 19,281 | | | | (3,119 | ) | | | 63 | | | (d) | | | 16,225 | |
Other revenues | | | 1,983 | | | | (58 | ) | | | (1 | ) | | (d) | | | 1,924 | |
Net investment gains (losses) | | | 597 | | | | (6 | ) | | | — | | | | | | 591 | |
Net derivative gains (losses) | | | 38 | | | | 508 | | | | (18 | ) | | (d) | | | 528 | |
| | | | | | | | | | | | | | | | | | |
Total revenues | | | 69,951 | | | | (8,746 | ) | | | 283 | | | | | | 61,488 | |
| | | | | | | | | | | | | | | | | | |
Expenses | | | | | | | | | | | | | | | | | | |
Policyholder benefits and claims | | | 38,714 | | | | (3,609 | ) | | | 195 | | | (d) | | | 35,300 | |
Interest credited to policyholder account balances | | | 5,610 | | | | (1,195 | ) | | | (63 | ) | | (d) | | | 4,352 | |
Policyholder dividends | | | 1,388 | | | | (32 | ) | | | 25 | | | (d) | | | 1,381 | |
Other expenses | | | 16,769 | | | | (1,538 | ) | | | 128 | | | (d), (h) | | | 15,359 | |
| | | | | | | | | | | | | | | | | | |
Total expenses | | | 62,481 | | | | (6,374 | ) | | | 285 | | | | | | 56,392 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations before provision for income tax | | | 7,470 | | | | (2,372 | ) | | | (2 | ) | | | | | 5,096 | |
Provision for income tax expense (benefit) | | | 2,148 | | | | (661 | ) | | | (1 | ) | | (j) | | | 1,486 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | 5,322 | | | | (1,711 | ) | | | (1 | ) | | | | | 3,610 | |
Less: Income (loss) from continuing operations attributable to noncontrolling interests | | | 12 | | | | — | | | | — | | | | | | 12 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations attributable to MetLife, Inc. | | | 5,310 | | | | (1,711 | ) | | | (1 | ) | | | | | 3,598 | |
Less: Preferred stock dividends | | | 116 | | | | — | | | | — | | | | | | 116 | |
Preferred stock repurchase premium | | | 42 | | | | — | | | | — | | | | | | 42 | |
| | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders | | $ | 5,152 | | | $ | (1,711 | ) | | $ | (1 | ) | | | | $ | 3,440 | |
| | | | | | | | | | | | | | | | | | |
Earnings per share | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income taxes, available to MetLife, Inc.’s common shareholders per common share: | | | | | | | | | | | | | | | | | | |
Basic | | $ | 4.61 | | | | | | | | | | | | | $ | 3.08 | |
| | | | | | | | | | | | | | | | | | |
Diluted | | $ | 4.57 | | | | | | | | | | | | | $ | 3.05 | |
| | | | | | | | | | | | | | | | | | |
Weighted average shares of common stock outstanding per common share: | | | | | | | | | | | | | | | | | | |
Basic | | | 1,117.8 | | | | | | | | | | | | | | 1,117.8 | |
| | | | | | | | | | | | | | | | | | |
Diluted | | | 1,128.3 | | | | | | | | | | | | | | 1,128.3 | |
| | | | | | | | | | | | | | | | | | |
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
5
MetLife, Inc.
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Year Ended December 31, 2014
(In millions, except per share data)
| | | | | | | | | | | | | | | | | | | | |
| | Historical MetLife, Inc. | | | Brighthouse Financial Separation (a) | | | Pro Forma Adjustments | | | Notes | | | Pro Forma MetLife, Inc. | |
Revenues | | | | | | | | | | | | | | | | | | | | |
Premiums | | $ | 39,067 | | | $ | (2,097 | ) | | $ | 436 | | | | (d) | | | $ | 37,406 | |
Universal life and investment-type product policy fees | | | 9,946 | | | | (4,122 | ) | | | (129 | ) | | | (d) | | | | 5,695 | |
Net investment income | | | 21,153 | | | | (3,067 | ) | | | — | | | | | | | | 18,086 | |
Other revenues | | | 2,030 | | | | (69 | ) | | | 5 | | | | (d) | | | | 1,966 | |
Net investment gains (losses) | | | (197 | ) | | | 484 | | | | — | | | | | | | | 287 | |
Net derivative gains (losses) | | | 1,317 | | | | (595 | ) | | | 63 | | | | (d) | | | | 785 | |
| | | | | | | | | | | | | | | | | | | | |
Total revenues | | | 73,316 | | | | (9,466 | ) | | | 375 | | | | | | | | 64,225 | |
| | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits and claims | | | 39,102 | | | | (3,709 | ) | | | 250 | | | | (d) | | | | 35,643 | |
Interest credited to policyholder account balances | | | 6,943 | | | | (1,217 | ) | | | (61 | ) | | | (d) | | | | 5,665 | |
Policyholder dividends | | | 1,376 | | | | (23 | ) | | | 17 | | | | (d) | | | | 1,370 | |
Other expenses | | | 17,091 | | | | (2,002 | ) | | | 199 | | | | (d), (h) | | | | 15,288 | |
| | | | | | | | | | | | | | | | | | | | |
Total expenses | | | 64,512 | | | | (6,951 | ) | | | 405 | | | | | | | | 57,966 | |
| | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations before provision for income tax | | | 8,804 | | | | (2,515 | ) | | | (30 | ) | | | | | | | 6,259 | |
Provision for income tax expense (benefit) | | | 2,465 | | | | (736 | ) | | | (10 | ) | | | (j) | | | | 1,719 | |
| | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax | | | 6,339 | | | | (1,779 | ) | | | (20 | ) | | | | | | | 4,540 | |
Less: Income (loss) from continuing operations attributable to noncontrolling interests | | | 27 | | | | — | | | | — | | | | | | | | 27 | |
| | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations attributable to MetLife, Inc. | | | 6,312 | | | | (1,779 | ) | | | (20 | ) | | | | | | | 4,513 | |
Less: Preferred stock dividends | | | 122 | | | | — | | | | — | | | | | | | | 122 | |
| | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.'s common shareholders | | $ | 6,190 | | | $ | (1,779 | ) | | $ | (20 | ) | | | | | | $ | 4,391 | |
| | | | | | | | | | | | | | | | | | | | |
Earnings per share | | | | | | | | | | | | | | | | | | | | |
Income (loss) from continuing operations, net of income taxes, available to MetLife, Inc.’s common shareholders per common share: | | | | | | | | | | | | | | | | | | | | |
Basic | | $ | 5.48 | | | | | | | | | | | | | | | $ | 3.89 | |
| | | | | | | | | | | | | | | | | | | | |
Diluted | | $ | 5.42 | | | | | | | | | | | | | | | $ | 3.85 | |
| | | | | | | | | | | | | | | | | | | | |
Weighted average shares of common stock outstanding per common share: | | | | | | | | | | | | | | | | | | | | |
Basic | | | 1,128.7 | | | | | | | | | | | | | | | | 1,128.7 | |
| | | | | | | | | | | | | | | | | | | | |
Diluted | | | 1,142.5 | | | | | | | | | | | | | | | | 1,142.5 | |
| | | | | | | | | | | | | | | | | | | | |
See accompanying notes to unaudited pro forma condensed consolidated financial statements.
6
MetLife, Inc.
Notes to the Unaudited Pro Forma
Condensed Consolidated Financial Statements
The following pro forma adjustments have been presented in the unaudited pro forma condensed consolidated financial statements.
(a) The Brighthouse Financial Separation column includes historical amounts reported by MetLife, Inc.’s Brighthouse Financial segment adjusted to exclude the impact of historical intercompany transactions between Brighthouse and MetLife, Inc. subsidiaries that had previously been eliminated in consolidation and to exclude previously allocated corporate overhead costs. The effect of the adjustments to the historical Brighthouse Financial segment information is as follows:
| | | | | | | | | | | | |
| | Historical | | | | | | | |
| | Brighthouse | | | | | | Brighthouse | |
| | Financial | | | | | | Financial | |
| | Segment | | | Adjustments | | | Separation | |
| | | | | (in millions) | | | | |
At June 30, 2017 | | | | | | | | | | | | |
Total Assets | | $ | (224,933 | ) | | $ | 3,067 | | | $ | (221,865 | ) |
Total Liabilities | | $ | (208,482 | ) | | $ | 2,149 | | | $ | (206,332 | ) |
Total Equity | | $ | (16,451 | ) | | $ | 968 | | | $ | (15,483 | ) |
For the six months ended June 30, 2017 | | | | | | | | | | | | |
Total Revenues | | $ | (2,990 | ) | | $ | (353 | ) | | $ | (3,343 | ) |
Total Expenses | | $ | (3,380 | ) | | $ | 239 | | | $ | (3,141 | ) |
For the year ended December 31, 2016 | | | | | | | | | | | | |
Total Revenues | | $ | (3,019 | ) | | $ | (28 | ) | | $ | (3,047 | ) |
Total Expenses | | $ | (7,321 | ) | | $ | 582 | | | $ | (6,739 | ) |
For the year ended December 31, 2015 | | | | | | | | | | | | |
Total Revenues | | $ | (8,770 | ) | | $ | 24 | | | $ | (8,746 | ) |
Total Expenses | | $ | (7,427 | ) | | $ | 1,053 | | | $ | (6,374 | ) |
For the year ended December 31, 2014 | | | | | | | | | | | | |
Total Revenues | | $ | (9,257 | ) | | $ | (209 | ) | | $ | (9,466 | ) |
Total Expenses | | $ | (7,980 | ) | | $ | 1,029 | | | $ | (6,951 | ) |
(b) Adjustment to reflect MetLife, Inc.’s retained interest of 22,996,436 shares of Brighthouse common stock at the date of the Distribution. For purposes of the unaudited pro forma condensed consolidated balance sheet, the fair value of MetLife, Inc.’s investment in Brighthouse was calculated using the number of shares retained by MetLife, Inc. multiplied by the opening trading price of Brighthouse common stock on August 7, 2017. After the Distribution, MetLife, Inc. will elect the fair value option for the investment and will record any subsequent changes in estimated fair value to net investment gains (losses) in continuing operations. The unaudited pro forma condensed consolidated statements of operations do not include adjustments for the retained interest because MetLife, Inc. cannot determine what the changes in fair value of the retained interest would have been had the Distribution occurred on January 1, 2014.
(c) Adjustments to reflect, at the time of Distribution, i) the recognition of previously deferred gains and asset basis adjustments and the related deferred tax assets and liabilities attributable to prior transactions between MetLife, Inc. and Brighthouse, ii) the recognition of a tax receivable and payable pursuant to tax agreements, iii) the recognition of a payable for certain employee matters and iv) the recognition of net deferred tax liabilities directly attributable to the Distribution.
(d) Adjustments to reflect reinsurance transactions, structured settlement assignment company transactions, distribution service fees, and investment management services fee revenue, including related outstanding balances between MetLife, Inc. and Brighthouse that were previously eliminated in consolidation, but that have a continuing impact on MetLife, Inc. post-Distribution. MetLife, Inc., as an assignment company, assumes structured settlement claim obligations and purchases annuities from Brighthouse to fund the periodic payment claim obligations. MetLife, Inc. also receives fees from Brighthouse for distribution services and investment management services. The adjustments for assignment company transactions impact other invested assets, other policy-related balances, net investment income and policyholder benefits and claims. The adjustments for distribution service fees impact universal life and investment-type product policy fees. The adjustment for investment management services fees impact other revenues.
7
(e) Adjustment to reflect the cash dividend from Brighthouse to MetLife, Inc. that occurred on August 3, 2017 in connection with the Distribution.
(f) Adjustments to reflect the impact to MetLife, Inc. total equity from the abovementioned pro forma adjustments.
(g) The book value per common share and book value per common share, excluding accumulated other comprehensive income (loss) (“AOCI”) and foreign currency translation adjustment (“FCTA”) are calculated using the common shares outstanding at the end of the period. Equity and book value details are as follows:
| | | | | | | | |
| | Historical MetLife, Inc. | | | Pro Forma MetLife, Inc. | |
| | June 30, 2017 | |
| | (In millions) | |
Equity | | | | | | | | |
Total MetLife, Inc.’s stockholders’ equity | | $ | 69,455 | | | $ | 55,948 | |
Less: Preferred stock | | | 2,066 | | | | 2,066 | |
| | | | | | | | |
MetLife, Inc.’s common stockholders’ equity | | | 67,389 | | | | 53,882 | |
Less: Net unrealized investment gains (losses), net of income tax | | | 15,038 | | | | 13,218 | |
Defined benefit plans adjustment, net of income tax | | | (1,923 | ) | | | (1,905 | ) |
| | | | | | | | |
Total MetLife, Inc.’s common stockholders’ equity, excluding AOCI other than FCTA | | $ | 54,274 | | | $ | 42,569 | |
| | | | | | | | |
| | |
Book Value | | | | | | | | |
Book value per common share | | $ | 63.37 | | | $ | 50.66 | |
Less: Net unrealized investment gains (losses), net of income tax | | | 14.15 | | | | 12.42 | |
Defined benefit plans adjustment, net of income tax | | | (1.81 | ) | | | (1.79 | ) |
| | | | | | | | |
Book value per common share, excluding AOCI other than FCTA | | $ | 51.03 | | | $ | 40.03 | |
| | | | | | | | |
(h) Adjustments to reflect the removal of historical interest expense related to financing arrangements terminated in connection with the Distribution. In addition, the adjustments include $294 million of fees expensed in 2017 to effect the terminations. Together, these adjustments include a $323 million, $107 million, $87 million, and $89 million decrease to other expenses for the six months ended June 30, 2017 and for the years ended December 31, 2016, 2015 and 2014, respectively.
(i) Adjustments to removenon-recurring separation costs that were incurred and included in MetLife, Inc.’s historical statements of operations of $113 million for the six months ended June 30, 2017 and of $212 million for the year ended December 31, 2016. These costs were primarily related to professional services and are not expected to have a continuing impact on MetLife, Inc. post-Distribution.
(j) Adjustments for the income tax impact for pro forma adjustments at the federal statutory tax rate of 35%.
8